Fresenius SE KGaA (XSWX:FRE) 3-Year Share Buyback Ratio: 0.00% (As of Mar. 2026)


XSWX:FRE Fresenius SE & Co KGaA XSWX:FRE
71 GF Score
Price CHF37.79
GF Value CHF32.58
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA 3-Year Share Buyback Ratio?

Fresenius SE KGaA XSWX:FRE 71 3-Year Share Buyback Ratio is 0.00 as of Mar. 2026. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF32.58 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 445 Healthcare Providers & Services companies, Fresenius SE KGaA ranks worse than 224718.88% on this metric.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Fresenius SE KGaA's current 3-Year Share Buyback Ratio was 0.00%.

The historical rank and industry rank for Fresenius SE KGaA's 3-Year Share Buyback Ratio or its related term are showing as below:

During the past 13 years, Fresenius SE KGaA's highest 3-Year Share Buyback Ratio was 0.20%. The lowest was -56.10%. And the median was -0.80%.

XSWX:FRE's 3-Year Share Buyback Ratio is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: -1.9
* Ranked among companies with meaningful 3-Year Share Buyback Ratio only.

Fresenius SE KGaA (XSWX:FRE) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


Fresenius SE KGaA 3-Year Share Buyback Ratio Related Terms


XSWX:FRE vs HCA, THC, DVA: 3-Year Share Buyback Ratio Comparison

For the Medical Care Facilities subindustry, Fresenius SE KGaA's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA 3-Year Share Buyback Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's 3-Year Share Buyback Ratio falls into.


XSWX:FRE
71GF Score
Fresenius SE & Co KGaA XSWX:FRE
3-Year Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius SE KGaA 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

What does a 3-Year Share Buyback Ratio of 0.00 mean?
Fresenius SE KGaA (XSWX:FRE) has a 3-Year Share Buyback Ratio of 0.00 as of Mar. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Fresenius SE KGaA and its competitors. According to the industry distribution chart, Fresenius SE KGaA ranks #999999 out of 445 companies in the Healthcare Providers & Services industry.
Is Fresenius SE KGaA's 3-Year Share Buyback Ratio too high?
Fresenius SE KGaA's current 3-Year Share Buyback Ratio is 0.00. Based on the distribution chart, Fresenius SE KGaA ranks #999999 out of 445 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's 3-Year Share Buyback Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #999999 out of 445 companies for 3-Year Share Buyback Ratio. This places Fresenius SE KGaA in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Healthcare Providers & Services company?
A good 3-Year Share Buyback Ratio depends on the Healthcare Providers & Services industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Fresenius SE KGaA and its competitors. Fresenius SE KGaA's current 3-Year Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF32.58, compared to a current price of CHF37.79 — trading 16% above its estimated fair value. The current 3-Year Share Buyback Ratio is 0.00. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current 3-Year Share Buyback Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of CHF37.79 is trading 16% above its estimated GF Value™ of CHF32.58. GuruFocus considers Fresenius SE KGaA to be Modestly Overvalued.

Key valuation signals for XSWX:FRE:

  • 3-Year Share Buyback Ratio: 0.00
  • GF Value™: CHF32.58 vs. price of CHF37.79 (16% above fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score

Get the complete analysis for XSWX:FRE

3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF37.79
Price
CHF32.58
GF Value